AKT1 and pancreatic ductal adenocarcinoma: Previously, we have shown in collaboration with Dr. Nagathihalli's group that treatment with UroA suppresses the PI3K/AKT/mTOR pathway in pancreatic ductal adenocarcinoma (PDAC) 79.